Last edition
News about "Toripalimab"
Dr. Reddy's launches NIVORZ in India
Dr. Reddy’s has launched NIVORZ, a nivolumab biosimilar in India, marking its entry into biosimilar immuno-oncology with approval across 12 cancer indications.
Toripalimab | 16/09/2026 | By News Bureau
Junshi Biosciences expands toripalimab’s treatment footprint in China with regulatory approval for a new urothelial carcinoma indication, strengthening immunotherapy options for patients with advanced bladder cancer.
Toripalimab | 25/05/2026 | By News Bureau | 145
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy